Al Beladi Fatma I
Department of Internal Medicine, Nephrology Division, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Saudi J Kidney Dis Transpl. 2010 Mar;21(2):323-7.
Painful violaceous skin lesions that progress to non-healing ulceration and gangrene characterize calciphylaxis. These lesions are associated with secondary hyperparathyroidism and generally occur in patients on dialysis for more than one year. Hyperphosphatemia and hypoalbuminemia are the major risk factors for calciphylaxis. It is usually resistant to medical treatment although parathyroidectomy can help in controlling the disease. The mortality rate of calciphylaxis is very high due to uncontrollable sepsis. In our case, a young female with systemic lupus erythematosus (SLE) developed calciphylaxis within a short period after the onset of hemodialysis; she had a short period of hyperphosphatemia prior to dialysis. The serum phosphate was 4.24 mmol/L, calcium was 1.66 mmol/L, parathormone was 38 and calcium-phosphate was 7.0 mmol/L. It is likely that SLE provoked the development of calciphylaxis. The patient was treated medically but unfortunately died secondary to sepsis.
疼痛性紫蓝色皮肤病变进展为不愈合性溃疡和坏疽是钙过敏的特征。这些病变与继发性甲状旁腺功能亢进有关,通常发生在透析一年以上的患者中。高磷血症和低白蛋白血症是钙过敏的主要危险因素。尽管甲状旁腺切除术有助于控制疾病,但它通常对药物治疗有抵抗性。由于无法控制的败血症,钙过敏的死亡率非常高。在我们的病例中,一名患有系统性红斑狼疮(SLE)的年轻女性在开始血液透析后短时间内发生了钙过敏;透析前她有一段短暂的高磷血症。血清磷酸盐为4.24 mmol/L,钙为1.66 mmol/L,甲状旁腺激素为38,钙磷为7.0 mmol/L。很可能是SLE引发了钙过敏的发展。该患者接受了药物治疗,但不幸的是因败血症继发死亡。